Surrozen IncDE
For the period ended Dec 31, 2023. Filed Apr 10, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 10, 2024
SRZN$32.64+2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
(In thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Operating activities: | ||
| Net loss | $(43,042) | $(36,004) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 1,911 | 1,955 |
| Stock-based compensation | 4,372 | 4,517 |
| Non-cash operating lease expense | 1,273 | 1,314 |
| Amortization of (discount) premium on marketable securities, net | (732) | 108 |
| Non-cash impairment of long-lived assets | 169 | — |
| Change in fair value of warrant liabilities | (211) | (7,890) |
| Gain on foreign currency remeasurement | (174) | |
| Other expense related to the commitment shares issued to Lincoln Park | — | 273 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | — | (1,978) |
| Prepaid expenses and other current assets | 915 | (50) |
| Other assets | 62 | (379) |
| Accounts payable | (133) | (2,038) |
| Accrued and other liabilities | (2,550) | (1,782) |
| Operating lease liabilities | (2,223) | (2,191) |
| Net cash used in operating activities | (40,363) | (44,145) |
| Investing activities: | ||
| Purchases of property and equipment | (398) | (728) |
| Purchases of marketable securities | (28,044) | (29,600) |
| Proceeds from maturities of marketable securities | 80,165 | 68,637 |
| Net cash provided by investing activities | 51,723 | 38,309 |
| Financing activities: | ||
| Proceeds from issuance of common stock upon exercise of stock options | 3 | — |
| Proceeds from issuance of common stock upon employee stock plan purchases | 332 | 143 |
| Repurchase and cancellation of common stock | — | (2,607) |
| Repurchase of warrants | — | (85) |
| Repurchase of early exercised stock options | (55) | (16) |
| Redemption of fractional shares due to reverse stock split | (4) | — |
| Net cash provided by (used in) financing activities | 276 | (2,565) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 11,636 | (8,401) |
| Cash, cash equivalents and restricted cash at beginning of year | 25,095 | 33,496 |
| Cash, cash equivalents and restricted cash at end of year | $36,731 | $25,095 |
| Supplemental disclosure of noncash investing and financing activities: | ||
| Purchases of property and equipment included in accounts payable and accrued expenses | $— | $85 |
| Vesting of early exercises of stock options | $32 | $101 |
The following table presents a reconciliation of the Company’s cash, cash equivalents and restricted cash in the Company’s consolidated balance sheets:
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Cash and cash equivalents | $36,043 | $24,690 |
| Restricted cash | 688 | 405 |
| Cash, cash equivalents and restricted cash | $36,731 | $25,095 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.